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ABSTRACT 
The recent clinical studies describing the treatment of some neurological disorders with an 
externally applied picoTesla (10-2 Tesla, or 10-8 gauss) magnetic field are considered from a 
physical view point. An equation relating the intrinsic (or "rest") energy of a charged particle 
of mass m with its energy of interaction in an externally applied magnetic field B is presented. 
The equation represents an initial basic physical interaction as a part of a more complex biolog­
ical mechanism to explain the therapeutic effects of externally applied magnetic fields in these 
and other neurologic disorders. 
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INTRODUCTION 

T he existence of the brain magnetic field and the difference between the magnetic field profile of the normal brain vs the pathologic brain, has been known from the classical work of Cohen1 and several recent works 
of others using the superconducting quantum interference detectors (SQUID) 
on patients with epilepsy and other neurologic disorders.2-6 These investigators 
measured the intensity profile of the human brain magnetic field and found 
that it is of the order of 0.5 pT (picoTesla) or 5 x 10-9 gauss. The work of 
Anninos, Tsagas, and Sandyk began with the notion that an externally applied 
magnetic field, slightly greater than the physiologic magnetic field, but still 
within the range of the physiologic brain magnetic field, may "realign" the 
4abnormal field profiles back to that associated with the normal brain.2­
Equipped with a SQUID they obtained the initial magneto encephalograph 
(MEG) profile, providing them with the foci, frequency, and intensity of the 
abnormal brain magnetic field. Subsequently, they used an array of small coils, 
contained in a flexible plastic patch attached to a patient's cranium, for treating 
several neurologic disorders, including epilepsy and multiple sclerosis. The 
specific focus areas, frequency, and field intensity were kept within the range 
of the pathologic MEG. They reported observable improvement in the post 
treatment MEG measurement and clinical examination of these patients. 
Recently Sandyk, using a similarly applied external magnetic field, confirmed 
their study by limiting the type of neurologic disorder to Parkinson's disease, 
and demonstrated with statistical significance the prolonged reduction of tremor 
in the hands of patients.5 
THEORY 
Several years prior to the above experimental works, Jacobson proposed an 
equation that the intensity B of the externally applied magnetic field can be 
specified for a pathologic particle (molecules, viruses, or bacteria) of mass m 
by Equation [1], 
[1J 
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where c is the velocity of light in vacuum, qj represents a unit charge i.e., qj :::: 1 
coulomb, by defining electromotive force as energy per unit charge, v is the 
velocity of the carrier or "string" in which the particle exists, and 1 is its 
dimension. The "string" can be of a submicroscopic to macroscopic 
2dimension.7-9 The mc is the intrinsic energy of the known or suspected 
pathogenic particle. The particle could be an abnormal portion of DNA or 
RNA, glycoprotein, virus, bacteria, abnormal chromosome, or portion of a 
chromosome. If the mass m of the particle is known, and a reasonable estimate 
for the length 1 of the "string" or the carrier where the pathogenic particle 
exists is made, then the intensity B of the magnetic field to be applied is 
specified using equation [1]. Equation [1J is derived as follows. The induced 
electromotive force (emf) Vi in an electrically conducting carrier (or "string") 
moving with velocity v through a magnetic field with intensity B is given by 
Faraday's law. 
V. Bvl [2JI 
The induced emf Vi is defined as energy E per unit charge, hence, 
V. 
1 
= E/q.J [3J 
equating the right hand sides of Equations [2] and [3J and solving for we 
have, 
[4J 
Equation [4] the energy E of the magnetic portion of the electromagnetic 
interaction in which the force F is expressed in terms of contributions from 
both electric field E and magnetic field B. 
F qE + qv x B [5J 
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Neglecting the contribution from E, and expressing the force F in Equation 
[5] in terms of the energy E, we have, 
[6] 
E quation [6J allows any value of angle e between the direction of Band that of v, whereas Equation [4] applies only for when B is orthogonal to v. Jacobson proposed that it is possible to select B (magnitude of 
B) and apply the magnetic component of the force whose energy is equal to 
the specific intrinsic energy mc2 of any particle by equating the right hand side 
of Equation [4] with mc2, arriving at Equation [1]. Assumptions made in 
deriving Equation [lJ are: (i) v and B are orthogonal, (ii) the contribution from 
electric field E in the Lorentz equation is neglected, (iii) the carrier, or "string" 
in which the particle exists can be mathematically treated as a one dimensional 
object, and (iv) the intrinsic energy of any charged particle can be made equal 
to its energy (product of force and dimension) in an externally applied magnetic 
field B by selecting the intensity B. 
RATIONALE FOR THE VELOCITY V AND 
STRING DIMENSION 1 
For the medical application of Equation [1], one of the authors OU) has chosen 
the inertial velocity v of the earth as the carrier velocities of biological systems, 
i.e., the orbital or rotational velocity of the earth. The selection of v depends 
on the observer's "point of view." An observer with the solar system (or 
planetary) point of view as one of the authors OIJ) may choose v as the orbital 
velocity of the earth, one with the terrestrial point of view may select the 
rotational velocity. Since the velocity of magnetic fields is c, the interaction 
between a magnetic field and the material particle is independent of the inertial 
frame of the earth. The rationale for the unidimensionality of the "string" or 
carrier is adapted from Einstein, who viewed the largest dimension of all three 
dimensional objects as the one most closely associated with its velocity.lO 
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RELATION TO OTHER RESONANCE 
PHENOMENA 
We consider Equation [1] with respect to other known magnetic resonance 
phenomena, namely, (a) ion cyclotron resonance, and (b) Zeeman interaction 
between charged particles and a static magnetic field. Furthermore, we treat 
the particle in these magnetic interactions as a charged DeBroglie wave particle. 
We first consider Equation [1] i.e., Jacobson resonance, in relation to the ion 
cyclotron resonance. When a point mass m with charge q is moving circularly 
with velocity v and radius r, in a magnetic field of intensity B perpendicular 
to the plane of the circular motion, the angular frequency of this circulating 
motion ooicr is 
00·lcr = vir qB/m [7] 
The frequency f = 00/2rc, so that, 
fler v/2rcr qB/2rcm [8] 
(cr is known as the ion cyclotron resonance frequency.ll,12 
When r = 1, and v = c, the Equation [8] becomes c/2rcl qB/2rcm; rearranging 
and multiply both sides by c we obtain, 
2mc = qcBl [9] 
Comparison of Equation [1] and [9] implies that for a charged point mass 
orbiting (e.g., electron, etc.) with velocity c, with radius 1, and q = q., ion 
cyclotron resonance and the Jacobson resonance are the same with res~ect to 
energy and frequency. 
Subtle Energies • 1994 • Volume 5 • Number 3 • Page 243 
Now, consider the DeBroglie particle wave. A particle of mass m, moving at 
velocity c, whose momentum p can be expressed by the DeBroglie's wavelength 
A, i.e., 
p = mc = h/A [10] 
where h is the Planck's constant. The intrinsic energy E of this particle may 
be obtained by multiplying both sides of Equation [10] by c, f is the frequency, 
lE = mc he!A = hf [11 ] 
Next, we treat this particle wave as a charged particle and place it in an externally 
applied magnetic field of a selected intensity B, such that the intrinsic energy of 
this DeBroglie wave particle is equal to the Zeeman resonance energy, i.e., 
[12] 
where g is either electron g-factor ge or nuclear g factor gn' and ~ is either 
Bohr magneton ~e or nuclear magneton ~n' The magneton is generally defined 
as 
~ = qh/41tm [13] 
land since for the DeBroglie particle, hf = hit = mc , and h = mc2t, substi­
tuting [13] into [12], the intrinsic energy E becomes 
[14] 
and dividing both sides by mcl and then by t yields the DeBroglie particle 
wave frequency as 
f = lit = gqB/41tm [15] 
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For the g 2 particle such as electron, this becomes f qB/21tm, which turns 
out to be the cyclotron resonance frequency. On the other hand, if we just 
calculate Zeeman resonance frequency, it is, 
f E/h = gPB/h gqBI 41tm [16] 
Equations [10] through [16] verify that for a charged particle in the magnetic 
field, ion cyclotron resonance and Zeeman resonance are the same with respect 
to particle's intrinsic energy, magnetic resonance energy and frequency. Next, 
we consider that a charged particle in the Jacobson resonance as a DeBroglie 
wave particle and calculate its resonance frequency ~r or energy Ejr from 
Equations [1] and [11] we have, 
f E./h [17]Jf Jr 
I n general, the particle frequency, the ion cyclotron resonance frequency, and Jacobson resonance frequency are not necessarily the same because of the possible range of the external magnetic field strength B. However, in 
order for the particle of Equation [1] to resonate with the ion cyclotron 
resonance frequency it must fulfill the following condition; 
f. = q.vBlIh qB/21tm [I8JJf-lcr J 
where ~r-icr is the frequency at which a particle resonates at a single frequency 
that satisfies both the Jacobson and ion cyclotron resonance equations. 
Simplifying Equation [18], and solving for the momentum mv, we arrive, 
mv [19] 
The condition turns out to be a DeBroglie equation in which the momentum 
of the particle needs to be equal to (q/q.)h/21tI, where 21tI is both the 
wavelength of that particle (A = 21t1) and the circumference of a loop (closed 
"string") with radius 1. Equation [19] states that the frequency (and energy) 
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of the Jacobson resonance and ion cyclotron resonance are the same when the 
above closed "string" or the wavelength condition is satisfied. Looking at the 
same condition in Equation [19] above in terms of the ratio q/qj, 
q/qj = 21tmvllh [20] 
or in terms of Bohr magneton ~e' Equation [19J can be rearranged to 
[21 J 
Conditions under which the energy and frequency of the Jacobson resonance become equal to those of the ion cyclotron resonance include: Equation [8] with v = c, and r = 1, and conditions derived from 
Equation [18J; Equation [19J for the particle momentum or wavelength, 
Equation [20] for the charge, and Equation [21] for the electronic or Bohr 
magneton. 
CORRELATION OF THEORY AND 
NEUROLOGICAL EXPERIMENTS 
Cohen measured the magnetic field intensity B of alpha brain waves to be 
about 1 x 10-9 gauss. He also found that there was a basis for believing that 
a dc magnetic field of about 5 x 10-8 gauss is associated with delta brain waves. l 
Cohen also measured maximum heart magnetic fields and found them to be 
about 5 x 10-7 gauss. With the knowledge that very weak magnetic fields, ten 
million times weaker than the geomagnetic field is produced in the brain, it 
was possible for Anninos et. al. to apply magnetic fields of the similar magnitude 
to epileptic foci and attenuate seizure activity.3,4 The field range of 1.2 x 10-7 
gauss to 3.0 x 1 gauss and a frequency range of 2-7 Hz were used in pericra­
nial treatment of over 100 epilepsy patients. 
For Parkinson's disease patients Sandyk used a 2 Hz, 7 x 10-8 gauss field, applied 
via a pad containing an array of small diameter coils, placed on patients' crania, 
and reported that the optomechanically measured tremor of hands and other 
symptoms were significantly reduced over two weeks. 5 
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For multiple sclerosis (MS) patients, the investigator used a 2-7 Hz, 7.5 x 10-8 
gauss field and patients showed improvement which was clinically observable 
and statistically significant.6 Equation [1] is used in calculating the theoret­
ical values of B. Using these B values and Equation [8] with q and m equal 
to the electronic charge and mass, it is possible to calculate the theoretical 
values for ion cyclotron resonance frequency. The values of v 3 x 106 em/sec, 
the orbital velocity of the earth, and I 1.7 x 102cm, the average height of 
the human were used for calculation for B. 
For Parkinson's disease, theoretical values B 7.5 x 10-8 gauss and f 2.1 Hz 
were obtained with use of m = 4.25 x 10-20 g, the mass of nerve growth factor 
(NGF). 
For MS, B 7.8 x 10-8 gauss and f 2.2 Hz were obtained with the use of 
m = 4.4 x 10-20 g, the mass of interferon. 
For epilepsy, the low theoretical values B 1.2 x 10-8 gauss and f .34 Hz 
were obtained with m 6.8 x 10-21 g, the mass of the smallest size antigen 
recognizable by the human immune system. 
For the high theoretical values, B 8.8 x 10-8 gauss and f 2.5 Hz were 
obtained with m = 5 x 10-20 g, the mass of platelet derived growth factor 
(PDGF). The comparison of the theoretical Band f with clinical B- and 
f-values are summarized in Table I. 
The B-values are ones reported by aforementioned clinical investigators and are 
average or mean values over the treated area. These values may contain at least 
± 0.5 x 10 gauss deviations. 
Furthermore, in the treatment for Parkinson's disease, it was the investigator's 
intention to focus the magnetic field to the pineal gland, whereas in the epilepsy 
study the ('feedback" of the reproduced EMG profile near the epileptic foci at 
the 2-7 Hz band was considered important. For this reason the epilepsy data 
were expressed in the range of fields instead of single values and may contain 
high and low values outside of the efficacious therapeutic values. Since the exact 
etiology of these neurologic disorders is not known, our selection of the 
molecular species is based upon the incomplete general knowledge of neurologic 
disease processes in which they are assumed to be closely involved. 
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Table I 

Comparison of Theoretical and Experimentally Determined 

Magnetic Field Strength B and Frequency f 

Disease Theoretical B (gauss) 
Parkinson 7.5x10-8 
MS 7.8 x 10-8 
Epilepsy 1.2 x 10-8(L) 











EXP 1 B (gauss) f (Hz) 
7.0x 10-8 2.0 
7.5 x 10-8 2-7 
0.3 x 10-8 2-7 
12 x 10-3 2-7 
OTHER CORRELATIONS 
In addition to the agreement between the theoretical (Equation [1]),8 and 
experimental magnetic field B-values and frequency f-values used in clinical 
neurological trials, we found that other studies which may not report benefi­
cial effects correlate with the theoretical Band f-values. Specifically, the f-value 
used by Goodman et. al. who demonstrated that human leukemia cells (HL60) 
exposed to ELF electromagnetic field exhibited significant changes in their gene 
16transcription, RNA synthesis, translation, and protein synthesis. 13- One of 
the frequencies of major interest in Goodman's work f 60 Hz, that of 
household and industrial AC electricity, can be predicted from Equation [8J 
with q/21tm = 7.6 x 102 coulomb g-l and B = 8.0 X 10-1 gauss. The B-value 
and the intrinsic/Lorentz energy value of 144 ergs is predicted from Equation [1] 
with oncogenic mass m 1.6 x 10-19g, earth's orbital velocity v 3 x 10-4cm 
sec-I, and cellular diameter I 6 x 10-4 cm. In the same context Equation [1] 
also predicts a growth factor of mass m = 4 x 10-20 g in a virus with length 
I 2.4 x 10-5 cm that will resonate at the intrinsic/Jacobson energy of 36 
ergs. 
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TRIAL B- AND F-VALUES FOR POSSIBLE 
MAGNETIC THERAPY 
Although Anninos, et. al. and Sandyk's data are, at this time, the only clinical 
data that were compared with Equation [1], it is of interest to predict the 
specific B-values computed from Equation [1], and f-values from Equation [8] 
for other diseases/disorders of unknown or vague etiology. One can calculate 
several trial values of B- and f-values computed from the mass m of the known, 
documented, or or suspected pathogens, or related molecular species which 
are closely associated to a specific disorder/disease process. These trial values 
should subsequently be tested experimentally for their efficacy. For example, 
for one of the possible treatments of AIDS, the mass of the envelop protein 
of the HIY, m 6.85 x 10-20 gI7, is used to obtain B = 1.2 x 10-7 gauss and 
f = 3.38 Hz. For a treatment of multiple myeloma, the mass of Bens Jones 
protein, m 7 x 10-20 g9, may be used to obtain B = 1.2 x 10-7 gauss and 
f = 3.50 Hz. 
SUMMARY 
T he intensity B of the externally applied magnetic field B and frequency f used in the recent successful clinical trials utilizing extremely weak (in picoTesla range) magnetic fields to treat patients with Parkinson's 
disease, epilepsy, and multiple sclerosis were correctly predicted from the 
Jacobson and ion cyclotron resonance equations (Equations [1] and [8] respec­
tively). The former is used to predict the B-values of possible therapeutic 
efficacy, from the known mass m of a molecular species suspected to be involved 
in the disease process. The latter was determined for the f-values of possible 
therapeutic efficacy, from the known mass m and B-values calculated with the 
use of Equation [1]. We conclude that the physical mechanism operative in 
the magneto therapy of neurological and other disorders includes both Jacobson 
and ion cyclotron resonance (or Zeeman resonance). The Jacobson resonance 
is used to predict B-values for any particle (including pathogenic particles), 
placed in an external magnetic field B, whereas the ion cyclotron resonance is 
used for predicting f-values of the charged ionic species (electrons, protons, 
Na+, K+, Ca+2, PO+3, etc.) placed in an external magnetic field B. For many 
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pathogenic or pathology related particles (molecular species), the B-value turns 
out to be in extremely weak pico Tesla range, and the f-value in the extremely 
low frequency (ELF) range. There are no criteria inherent in either theory for 
determining whether the effect of magnetic field on biological systems is benefi­
cial or hazardous. 
DISCUSSION 
T he clinical data such as restoration to normal, after treatment (EMG profile), improved clinical symptoms, and laboratory analysis of blood and sera need ro be correlated with changes in molecular structure, 
conformation, and other molecular, cellular, or histological properties resulting 
from the exposure to the pico Tesla magnetic field. The following remain to be 
determined: (i) the specific nature of the molecular, cellular, or histological 
changes, (ii) the evidence that magnetically induced photons can cause such 
molecular or microscopic changes, and (iii) the effects of such initial molecular, 
macromolecular, or microbiological changes on the known biochemical 
pathways of human endocrinology, immunology, and genetics, and (iv) the 
experimental determination of the criteria separating beneficial from hazardous 
or undesirable magnetic field effects. 
The fundamental concept implicit in Equation [1] (i.e., assumption (iv) on 
page 242) is Einstein's view that gravitational ether exists, and participates in 
the motion of ordinary matter. In addition it provides the medium for electro­
magnetic fields. He stated that every day reality compels us to believe that the 
causal linking of natural phenomena involves the communication of motion 
through impact or contact. 14 The Kalusa-Kline theory assigned a fifth coordi­
nate for gravity in unifYing gravity with electromagnetism. i5 Supersymmetry 
and superstring theoreticians accomplished a similar abstract mathematical 
unification by proposing the concept of shadow-matter (or dark matter) and 
several additional dimensions. 16,17 The Newtonian action at a distance concepts 
which do not account for the force carrier in free space were not accepted by 
either Einstein or modern theoreticians. 
Further theoretical details which need to be addressed include: magnetic 
anisotropies typical m crystalline and liquid crystalline materials, magnetic 
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interactions such as Fermi contact (or electron nuclear hyperfine interactions) 
in free radicals, electron dipole-dipole interactions in the photo-excited triplet 
states and stable paired radicals, or electron spin orbit (Russel-Saunders) 
coupling in organo-transition metal complexes. All of these magnetic interac­
tions further split the Zeeman energy levels into several discreet energy levels. 
Spin-orbit and electron dipole-dipole interactions exist at zero applied field and 
hence the pathogenic particles that may contain these interactions may require 
corrections arising from these additional magnetic interaction terms 
(Hamil tonians). 
Another important consideration is that the MEG profile of a normal individual 
may vary depending on the state of his mind. The MEG profiles corresponding 
to the alpha waves, and those corresponding to the theta waves are expected 
to be different. What constitutes the normal MEG profile? Is the efficacy of 
magneto-therapy distinguishable from the psychological effect of the patients 
on receiving a therapy? Future clinical studies should be designed to answer 
some of these questions. 
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